Compounds > avapro
Page last updated: 2024-10-29

avapro and Anemia

avapro has been researched along with Anemia in 4 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.

Research Excerpts

ExcerptRelevanceReference
" Risk factors for diabetic nephropathy are discussed, and include hyperglycemia, hypertension, angiotensin II, proteinuria, dyslipidemia, smoking, and anemia."4.82Outcome studies in diabetic nephropathy. ( Mohanram, A; Toto, RD, 2003)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghali, JK1
Mohanram, A1
Toto, RD1
Simonetti, GD1
Bianchetti, MG1
Konrad, M1
von Vigier, RO1
Schwarzbeck, A1
Wittenmeier, KW1
Hällfritzsch, U1

Reviews

1 review available for avapro and Anemia

ArticleYear
Outcome studies in diabetic nephropathy.
    Seminars in nephrology, 2003, Volume: 23, Issue:3

    Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme

2003

Other Studies

3 other studies available for avapro and Anemia

ArticleYear
Irbesartan for heart failure with preserved ejection fraction.
    The New England journal of medicine, 2009, Mar-19, Volume: 360, Issue:12

    Topics: Anemia; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Creatinine; Heart Failure; Hosp

2009
Severe anemia caused by the angiotensin receptor blocker irbesartan after renal transplantation.
    Pediatric nephrology (Berlin, Germany), 2007, Volume: 22, Issue:5

    Topics: Anemia; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Child; Erythropoietin; Hemoglob

2007
Anaemia in dialysis patients as a side-effect of sartanes.
    Lancet (London, England), 1998, Jul-25, Volume: 352, Issue:9124

    Topics: Anemia; Antihypertensive Agents; Biphenyl Compounds; Hemoglobins; Humans; Irbesartan; Kidney Transpl

1998